Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
基本信息
- 批准号:8402151
- 负责人:
- 金额:$ 7.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcroleinAcuteAddressAerosolsAffectAfferent NeuronsAnalgesicsAsthmaBehavioralBiochemicalBiological FactorsBreathingC FiberChemicalsChronicChronic Obstructive Airway DiseaseCigaretteCigarette smoke-induced emphysemaCotinineCoughingDependenceDevicesDiseaseElectronicsExposure toFamily Smoking Prevention and Tobacco Control ActFlavoringFoodGene FamilyGoalsHealthHypertensionHypesthesiaImageIndividualInflammationInflammatoryInflammatory ResponseInhalation ExposureIon ChannelIrritantsLung InflammationLung diseasesMalignant neoplasm of lungMarketingMediatingMentha piperitaMentholMinorityModelingMolecularMolecular TargetMouse StrainsMusNerve FibersNeuronsNeuropeptidesNicotineNicotine DependenceNociceptionOutcomePhysiologicalPneumoniaPopulationProcessProtein IsoformsPublishingPulmonary EmphysemaReceptor SignalingRegulationResearchRespiratory SystemRoleSensorySerumSmokeSmokerSmokingSystemTRPA1 ChannelTaste PerceptionTerpenesTestingTherapeuticTimeTobaccoTobacco IndustryTobacco smokeToxic effectaddictionafferent nervebasecigarette smokinginsightirritationlinaloolmouse modelpublic health relevancereceptorresearch studyrespiratoryrespiratory reflexresponsesmoke inhalationvapor
项目摘要
DESCRIPTION (provided by applicant): The tobacco industry has added a wide range of chemicals to cigarettes to increase product stability and modify taste and sensory qualities of smoke. While the Family Smoking Prevention and Tobacco Control Act outlawed tobacco flavor additives, menthol was exempt from regulation. Mentholated cigarettes are especially popular with beginning smokers and in minority populations disproportionally affected by COPD, lung cancer and hypertension. Recently, electronic cigarettes, marketed as non-toxic nicotine delivery devices, have become popular tobacco cigarette substitutes. Electronic cigarettes contain large amounts of the same chemical flavor and sensory additives outlawed for use in tobacco cigarettes, including irritating terpenes such as linalool. Our research has shown that menthol, at levels similar or below in smoke of mentholated cigarettes, strongly inhibited the respiratory irritation response to tobacco smoke irritants in mice. Aerosols from electronic cigarettes elicited strong irritation responses in mice, comparable to responses elicited by tobacco cigarette smoke. Physiological experiments showed that menthol and linalool are potent modulators of TRPM8 and TRPA1, two chemosensory ion channels expressed in sensory neurons innervating the respiratory system. We hypothesize that: 1.) Menthol acts as a counterirritant, blocking sensory neuronal responses to inhaled noxious chemicals through interaction with TRPA1 or TRPM8, 2) As a tobacco additive, menthol facilitates smoke inhalation through inhibition of neuronal irritant receptor signalling, thereby accelerating nicotie dependence and lung disease and , 3) the high amounts of chemical additives in electronic cigarettes are added to mimic the sensory impact of tobacco smoke and may cause chronic irritation and inflammatory responses. The studies proposed in this application will use physiological, biochemical, molecular and behavioral approaches to: Aim 1.) Define the roles of TRPA1 and TRPM8 in menthol-induced inhibition of acute respiratory irritation. Aim 2.) Examine the pharmacological effects of menthol and menthol-related compounds on irritant-induced activation of sensory neurons. Aim 3.) Determine the effects of menthol inhalation on smoking-induced lung inflammation and emphysema. Aim 4.) Investigate the sensory and inflammatory effects of electronic cigarette aerosols and their chemical additives. Our proposed research will provide new insights into neuronal mechanisms of airway irritation and remodeling, and define a scientific basis for regulatory efforts targeting menthol and other additives to tobacco and electronic cigarettes.
描述(由申请人提供):烟草业在卷烟中添加了多种化学品,以提高产品稳定性并改变烟雾的味道和感官品质。虽然《家庭吸烟预防和烟草控制法》禁止烟草香精添加剂,但薄荷醇不受监管。含薄荷醇的卷烟特别受初吸烟者和受慢性阻塞性肺病、肺癌和高血压影响的少数人群的欢迎。最近,作为无毒尼古丁输送装置销售的电子烟已成为流行的烟草替代品。电子烟含有大量与烟草香烟相同的化学香料和感官添加剂,其中包括芳樟醇等刺激性萜烯。我们的研究表明,薄荷醇含量与含薄荷醇的香烟烟雾中的含量相似或更低,可强烈抑制小鼠对烟草烟雾刺激物的呼吸道刺激反应。电子烟的气溶胶在小鼠体内引起强烈的刺激反应,与烟草烟雾引起的反应相当。生理实验表明,薄荷醇和芳樟醇是 TRPM8 和 TRPA1 的有效调节剂,TRPM8 和 TRPA1 是在支配呼吸系统的感觉神经元中表达的两种化学感应离子通道。我们假设:1.) 薄荷醇起到反刺激剂的作用,通过与 TRPA1 或 TRPM8 相互作用,阻断感觉神经元对吸入有毒化学物质的反应,2) 作为烟草添加剂,薄荷醇通过抑制神经元刺激受体信号传导促进烟雾吸入,从而加速尼古丁的产生依赖性和肺部疾病,3)电子烟中添加了大量的化学添加剂,以模仿烟草烟雾的感官影响,并可能导致慢性刺激和炎症反应。本申请中提出的研究将使用生理、生化、分子和行为方法来: 目标 1.) 定义 TRPA1 和 TRPM8 在薄荷醇诱导的急性呼吸道刺激抑制中的作用。目标 2.) 检查薄荷醇和薄荷醇相关化合物对刺激物诱导的感觉神经元激活的药理作用。目标 3.) 确定吸入薄荷醇对吸烟引起的肺部炎症和肺气肿的影响。目标 4.) 研究电子烟气雾剂及其化学添加剂的感官和炎症影响。我们提出的研究将为气道刺激和重塑的神经元机制提供新的见解,并为针对烟草和电子烟的薄荷醇和其他添加剂的监管工作确定科学基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SVEN-ERIC JORDT其他文献
SVEN-ERIC JORDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SVEN-ERIC JORDT', 18)}}的其他基金
Nicotine Pouches: Chemical Composition, Toxicity and Behavioral Effects of a New Tobacco Product Category
尼古丁袋:新型烟草产品类别的化学成分、毒性和行为影响
- 批准号:
10673370 - 财政年份:2022
- 资助金额:
$ 7.44万 - 项目类别:
Anesthetic and synthetic cooling flavors in E-cigarettes: Chemistry and respiratory effects modulating nicotine intake
电子烟中的麻醉剂和合成清凉香料:调节尼古丁摄入量的化学和呼吸效应
- 批准号:
9982329 - 财政年份:2018
- 资助金额:
$ 7.44万 - 项目类别:
Mechanisms of Itch in Poison Ivy-Induced Allergic Contact Dermatitis
毒藤引起的过敏性接触性皮炎的瘙痒机制
- 批准号:
9164682 - 财政年份:2016
- 资助金额:
$ 7.44万 - 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
- 批准号:
8900466 - 财政年份:2012
- 资助金额:
$ 7.44万 - 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
- 批准号:
8547809 - 财政年份:2012
- 资助金额:
$ 7.44万 - 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
- 批准号:
8416589 - 财政年份:2012
- 资助金额:
$ 7.44万 - 项目类别:
Counterirritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇的抗刺激作用:分子靶标及其在气道疾病中的作用
- 批准号:
8022797 - 财政年份:2011
- 资助金额:
$ 7.44万 - 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
- 批准号:
8209236 - 财政年份:2011
- 资助金额:
$ 7.44万 - 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
- 批准号:
8580913 - 财政年份:2011
- 资助金额:
$ 7.44万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Early life bladder inflammatory events in female mice lead to subsequent LUTS in adulthood
雌性小鼠生命早期的膀胱炎症事件导致成年后的 LUTS
- 批准号:
10638866 - 财政年份:2023
- 资助金额:
$ 7.44万 - 项目类别:
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
提高我们对电子烟或电子烟产品使用相关肺损伤的机制理解
- 批准号:
10115186 - 财政年份:2020
- 资助金额:
$ 7.44万 - 项目类别:
E-cigarette aerosol effects on the cardiovascular system in rodents
电子烟气溶胶对啮齿类动物心血管系统的影响
- 批准号:
10227000 - 财政年份:2018
- 资助金额:
$ 7.44万 - 项目类别:
Lipid metabolites can both potentiate and treat alcoholic hepatitis
脂质代谢物可以增强和治疗酒精性肝炎
- 批准号:
10441376 - 财政年份:2018
- 资助金额:
$ 7.44万 - 项目类别:
Lipid metabolites can both potentiate and treat alcoholic hepatitis
脂质代谢物可以增强和治疗酒精性肝炎
- 批准号:
9791137 - 财政年份:2018
- 资助金额:
$ 7.44万 - 项目类别: